Treatment of childhood astrocytomas with irinotecan and cisplatin.

about

Treatment of childhood astrocytomas with irinotecan and cisplatin.

Item

http://www.wikidata.org/entity/Q48204130

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Treatment of childhood astrocytomas with irinotecan and cisplatin.

@en

Treatment of childhood astrocytomas with irinotecan and cisplatin.

@nl

type

Item

label

Treatment of childhood astrocytomas with irinotecan and cisplatin.

@en

Treatment of childhood astrocytomas with irinotecan and cisplatin.

@nl

prefLabel

Treatment of childhood astrocytomas with irinotecan and cisplatin.

@en

Treatment of childhood astrocytomas with irinotecan and cisplatin.

@nl

P1476

Treatment of childhood astrocytomas with irinotecan and cisplatin

@en

P2093

S Perez-Jaume

http://www.w3.org/2001/XMLSchema#string

P2860

Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.

Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.

Temozolomide in children with progressive low-grade glioma.

Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence.

Pediatric low-grade gliomas and the need for new options for therapy: Why and how?

Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study.

Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin.

Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

P2888

s12094-017-1741-z

P304

500-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-017-1741-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jaume Mora

Ofelia Cruz

P577

2017-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28828715

http://www.w3.org/2001/XMLSchema#string